Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival

12 August 2022 : Original article

Ion Mărunţelu^12ABCDEF, Claudiu Eduard Nistor

^2CEF*, Bogdan Mihai Cristea^2CE, Corina Andreea Rotarescu^12BCD, Andreea Mirela Caragea^2B, Maria Tizu^2B, Ileana Constantinescu^12AD

DOI: 10.12659/AOT.937267

Ann Transplant 2022; 27:e937267

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Outcome in patients with or without de novo HLA antibodies.

	With preexisting HLA antibodies n=27	With de novo HLA antibodies n=48	P value
T-cell-mediated rejection	13 (48.15%)	19 (39.58%)	0.627
Antibody-mediated rejection	7 (25.93%)	10 (20.83%)	0.775
HLA – human leukocyte antigen.

Back to the Article